Dr. N. Krishna Reddy Appointed CEO of ACCESS Health International
India- January 2024- Significant leadership changes have been announced by ACCESS Health International. Dr. William Haseltine will step down from his position as... Read more.
Guardant Health, Hikma Partner for Cancer Screening in MENA
California, USA- January 2024- Guardant Health, a prominent precision oncology company, and Hikma Pharmaceuticals PLC, a multinational pharmaceutical company, have... Read more.
SKIN111 Clinic Opens 3000 sq. ft Center at Nakheel Mall, Palm Jumeirah
Dubai – January 8th, 2024: SKIN111 Medical & Aesthetic Clinic, an award-winning premium chain of health, wellness and aesthetic centres and the number one... Read more.
Avalon Pharma to float on Saudi Exchange’s main market
Riyadh, Saudi Arabia- January 2024- One of the Kingdom of Saudi Arabia’s fastest-growing domestic pharmaceutical manufacturing firms, Middle East Pharmaceutical... Read more.
Mark Your Calendar: Abbott Q4 Earnings Call Coming Soon?
Abbott Park- On Wednesday, January 24, Abbott will release its financial results for the fourth quarter(Q4) of 2023 before the opening of the market. After the release,... Read more.
Only one Day left: DUPHAT 2024 is set to kick off tomorrow
Dubai, UAE- January 2024- The largest-ever Dubai International Pharmaceutical Technologies Conference and Exhibition, or DUPHAT 2024, will take place at the Dubai... Read more.
Did Medtronic Attain CE Mark for Its Latest Micra Leadless Pacing Systems?
Dublin, Ireland- January 2024- The CE (Conformité Européenne) Mark approval for the MicraTM AV2 and MicraTM VR2 by Medtronic plc, a prominent player in the healthcare... Read more.
Varian and Nova Scotia Health’s Oncology Partnership for Cancer Advancements
Germany- January 2024- Nova Scotia Health and Varian, a Siemens Healthineers firm, have partnered in an unprecedented multi-disciplinary oncology partnership (MDOP)... Read more.
Novartis boosts Pluvicto production with new Indianapolis facility
Basel, Switzerland- January 2024- Novartis has gained approval from the US Food and Drug Administration (FDA) for the commercial manufacturing of PluvictoTM (lutetium... Read more.
Game-Changing Cancer Treatment: AbbVie and Umoja Biopharma Partner Up
North Chicago, USA- Pharmaceutical giant AbbVie and early clinical-stage biotech company Umoja Biopharma are teaming up for a groundbreaking venture to develop in-situ... Read more.
